What we do—

Changing the world

UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.

Read More
Latest news—

AstronauTx secures investment from UCL Technology Fund to further new approaches to dementia therapeutics

Read More
Featured Technology—

Quadruplex-binding compounds – a novel anticancer strategy

We have a first-in-class optimized small-molecule drug candidate ready for IND enabling studies with superior efficacy and activity against pancreatic cancer compared to existing agents, together with a distinct mechanism of action.

Read more
Spotlight—

How does Portico Ventures support non-patentable and fast-to-deploy technologies?

The following interview took place in April 2019 towards the end of the one-year pilot phase of Portico Ventures. Following positive feedback from the Department of Computer Science where the pilot ran, Portico Ventures is now rolling out more widely across the university. Visit our newsroom to find out more.

Read More
Featured Technology—

SnakeGrid

SnakeGrid is a way of developing low-distortion coordinate systems for large engineering projects.

Read more

Latest news and highlights

Read More News

AstronauTx secures investment from UCL Technology Fund to further new approaches to dementia therapeutics

/ UCLTF News
London, UK 24 March, 2020 AstronauTx Ltd, a biotech company developing new medicines designed to restore the normal behaviour of ...

Freeline Therapeutics appoints new Chief Medical Officer

/ UCLB News
The biotechnology company focused on developing curative gene therapies for chronic systemic diseases has announced the appointment of Julie Krop ...

UCLB Annual Report 2018/19

/ Annual Reports
Download the UCLB Annual Report as a PDF ...

Professor Sergio Quezada appointed as Chief Scientific Officer of Achilles Therapeutics

/ Spinout News
Achilles Therapeutics has announced the appointment of Professor Sergio Quezada of the UCL Cancer Institute as Chief Scientific Officer with ...

FIND THE RIGHT MATCH

Whether you’re an academic or looking for technologies, find your UCLB contact here.

 

Commercialising technology since 1993

0
Spinout companies in the UCLB portfolio
0
Active licences
0
Drug discovery projects in development
0
New UK patent applications

As of July 2019